30
Participants
Start Date
August 31, 2005
Primary Completion Date
January 31, 2008
Study Completion Date
March 31, 2008
Bevacizumab
3 intravenous infusions of 5mg/kg bevacizumab at 2 weeks intervals
Sodium Chloride
3 intravenous infusions of 100ml sodium chloride 0,9% at 2 weeks intervals
Dept. of Ophthalmology, Rudolf Foundation Clinic, Vienna
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
OTHER